These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38335183)

  • 61. Integration of Proteomics and Transcriptomics Data Sets for the Analysis of a Lymphoma B-Cell Line in the Context of the Chromosome-Centric Human Proteome Project.
    Díez P; Droste C; Dégano RM; González-Muñoz M; Ibarrola N; Pérez-Andrés M; Garin-Muga A; Segura V; Marko-Varga G; LaBaer J; Orfao A; Corrales FJ; De Las Rivas J; Fuentes M
    J Proteome Res; 2015 Sep; 14(9):3530-40. PubMed ID: 26216070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Integrating Genetics, Transcriptomics, and Proteomics in Lung Tissue to Investigate Chronic Obstructive Pulmonary Disease.
    Zhang YH; Cho MH; Morrow JD; Castaldi PJ; Hersh CP; Midha MK; Hoopmann MR; Lutz SM; Moritz RL; Silverman EK
    Am J Respir Cell Mol Biol; 2023 Jun; 68(6):651-663. PubMed ID: 36780661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparing Radiomics features of tumour and healthy liver tissue in a limited CT dataset: A machine learning study.
    Lysdahlgaard S
    Radiography (Lond); 2022 Aug; 28(3):718-724. PubMed ID: 35428570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
    McLean Diaz P; Vannier A; Joshi AD; Mahle RE; Przybyszewski EM; Corey K; Chung RT; Luther J; Goodman RP; Schaefer EAK
    Clin Transl Gastroenterol; 2023 Jun; 14(6):e00585. PubMed ID: 36972232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
    Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
    Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
    [No Abstract]   [Full Text] [Related]  

  • 66. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.
    Toh SH; Prathipati P; Motakis E; Kwoh CK; Yenamandra SP; Kuznetsov VA
    BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S24. PubMed ID: 22369099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How (Not) to Generate a Highly Predictive Biomarker Panel Using Machine Learning.
    Desaire H
    J Proteome Res; 2022 Sep; 21(9):2071-2074. PubMed ID: 36004690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH.
    Conway J; Pouryahya M; Gindin Y; Pan DZ; Carrasco-Zevallos OM; Mountain V; Subramanian GM; Montalto MC; Resnick M; Beck AH; Huss RS; Myers RP; Taylor-Weiner A; Wapinski I; Chung C
    Cell Rep Med; 2023 Apr; 4(4):101016. PubMed ID: 37075704
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema.
    Suryadevara R; Gregory A; Lu R; Xu Z; Masoomi A; Lutz SM; Berman S; Yun JH; Saferali A; Ryu MH; Moll M; Sin DD; Hersh CP; Silverman EK; Dy J; Pratte KA; Bowler RP; Castaldi PJ; Boueiz A;
    Am J Respir Crit Care Med; 2024 Feb; 209(3):273-287. PubMed ID: 37917913
    [No Abstract]   [Full Text] [Related]  

  • 70. Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model.
    Kan F; Ye L; Yan T; Cao J; Zheng J; Li W
    BMC Genomics; 2017 Aug; 18(1):641. PubMed ID: 28830339
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
    Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
    Front Immunol; 2022; 13():923031. PubMed ID: 35924241
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature.
    Trivizakis E; Koutroumpa NM; Souglakos J; Karantanas A; Zervakis M; Marias K
    Biomed Eng Online; 2023 Dec; 22(1):125. PubMed ID: 38102586
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Integrated Analysis of Transcriptome and Proteome of the Human Cornea and Aqueous Humor Reveal Novel Biomarkers for Corneal Endothelial Cell Dysfunction.
    Moon CE; Kim CH; Jung JH; Cho YJ; Choi KY; Han K; Seo KY; Lee HK; Ji YW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895034
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture.
    Kishore A; Venkataramana L; Prasad DVV; Mohan A; Jha B
    Med Biol Eng Comput; 2023 Nov; 61(11):2895-2919. PubMed ID: 37530887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prediction of Weight Loss to Decrease the Risk for Type 2 Diabetes Using Multidimensional Data in Filipino Americans: Secondary Analysis.
    Chang L; Fukuoka Y; Aouizerat BE; Zhang L; Flowers E
    JMIR Diabetes; 2023 Apr; 8():e44018. PubMed ID: 37040172
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis.
    Janša V; Pušić Novak M; Ban Frangež H; Rižner TL
    Hum Reprod; 2023 Jul; 38(7):1284-1296. PubMed ID: 37187159
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis.
    Eberhardt C; Thillai M; Parker R; Siddiqui N; Potiphar L; Goldin R; Timms JF; Wells AU; Kon OM; Wickremasinghe M; Mitchell D; Weeks ME; Lalvani A
    PLoS One; 2017; 12(1):e0170285. PubMed ID: 28114394
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis.
    Avitabile E; Díaz A; Montironi C; Pérez-Guasch M; Gratacós-Ginès J; Hernández-Évole H; Moreira RK; Sehrawat TS; Malhi H; Olivas P; Hernández-Gea V; Bataller R; Shah VH; Kamath PS; Ginès P; Pose E
    Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3080-3088.e9. PubMed ID: 37004974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach.
    Collins BC; Miller CA; Sposny A; Hewitt P; Wells M; Gallagher WM; Pennington SR
    Mol Cell Proteomics; 2012 Aug; 11(8):394-410. PubMed ID: 22527513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.